share_log

John E. Kao Sells 500,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

John E. Kao Sells 500,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

高曉鬆出售50,000股Align Healthcare,Inc.(納斯達克代碼:ALHC)股票
kopsource ·  2022/08/12 19:32

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) CEO John E. Kao sold 500,000 shares of the business's stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $15.95, for a total transaction of $7,975,000.00. Following the completion of the transaction, the chief executive officer now directly owns 2,849,200 shares of the company's stock, valued at $45,444,740. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Align Healthcare,Inc.(納斯達克代碼:ALHC-GET Rating)首席執行官約翰·E·高在一筆日期為8月11日(星期四)的交易中出售了500,000股該公司股票。股票以15.95美元的平均價格出售,總成交金額為7975,000.00美元。交易完成後,首席執行官現在直接擁有該公司2,849,200股股票,價值45,444,740美元。這筆交易是在提交給美國證券交易委員會(Securities&Exchange Commission)的一份法律文件中披露的,該文件可通過以下超級鏈接獲得。

Alignment Healthcare Trading Up 2.4 %

Align Healthcare交易上漲2.4%

NASDAQ ALHC traded up $0.38 during trading on Friday, reaching $16.48. 623,524 shares of the stock traded hands, compared to its average volume of 607,744. The firm has a market cap of $3.09 billion, a price-to-earnings ratio of -20.06 and a beta of 2.05. The stock's 50-day moving average price is $13.28 and its 200 day moving average price is $10.81. The company has a quick ratio of 2.74, a current ratio of 2.74 and a debt-to-equity ratio of 0.52. Alignment Healthcare, Inc. has a fifty-two week low of $6.14 and a fifty-two week high of $23.35.

納斯達克ALHC在週五的交易中上漲了0.38美元,達到16.48美元。該股共有623,524股易手,而其平均成交量為607,744股。該公司的市值為30.9億美元,市盈率為-20.06倍,貝塔係數為2.05。該股的50日移動均線價格為13.28美元,200日移動均線價格為10.81美元。該公司的速動比率為2.74,流動比率為2.74,債務權益比率為0.52。Align Healthcare,Inc.的股價為6.14美元,為52周低點,52周高點為23.35美元。

Get
到達
Alignment Healthcare
調整醫療保健
alerts:
警報:

Alignment Healthcare (NASDAQ:ALHC – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.20. Alignment Healthcare had a negative net margin of 11.20% and a negative return on equity of 47.96%. During the same period in the previous year, the firm earned ($0.25) earnings per share. Analysts predict that Alignment Healthcare, Inc. will post -0.81 EPS for the current year.

Align Healthcare(納斯達克:ALHC-GET Rating)最近一次發佈季度收益報告是在8月4日(星期四)。該公司公佈本季度每股收益(0.06美元),比普遍預期的(0.26美元)高出0.20美元。Align Healthcare的淨利潤率為負11.20%,股本回報率為負47.96%。去年同期,該公司每股收益為0.25美元。分析師預測,Align Healthcare,Inc.將公佈本年度每股收益為0.81美元。

Analyst Upgrades and Downgrades

分析師升級和下調評級

Several equities research analysts have recently commented on ALHC shares. Morgan Stanley lifted their price target on shares of Alignment Healthcare from $18.00 to $19.00 and gave the stock an "overweight" rating in a research report on Wednesday. The Goldman Sachs Group lifted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock a "buy" rating in a research report on Monday. Piper Sandler lifted their price target on shares of Alignment Healthcare from $15.00 to $20.00 and gave the stock an "overweight" rating in a research report on Friday, August 5th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a research report on Thursday, May 5th. Finally, Barclays lifted their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a research report on Monday. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $18.20.
幾位股票研究分析師最近對ALHC的股票發表了評論。週三,摩根士丹利在一份研究報告中將Align Healthcare的目標價從18.00美元上調至19.00美元,並給予該股“增持”評級。高盛夫婦在週一的一份研究報告中將Align Healthcare的目標價從14.00美元上調至21.00美元,並給予該股“買入”評級。派珀·桑德勒在8月5日星期五的一份研究報告中將Align Healthcare的目標價從15.00美元上調至20.00美元,並給予該股“增持”評級。威廉·布萊爾在5月5日(星期四)的一份研究報告中重申了對Align Healthcare股票的“跑贏大盤”評級。最後,巴克萊將Align Healthcare的目標價從14.00美元上調至21.00美元,並在週一的一份研究報告中給予該股“增持”評級。一名投資分析師對該股的評級為持有,10名分析師對該股的評級為買入。根據MarketBeat的數據,該股目前的平均評級為“適度買入”,共識目標價為18.20美元。

Institutional Inflows and Outflows

機構資金流入和流出

Several institutional investors and hedge funds have recently made changes to their positions in ALHC. Nisa Investment Advisors LLC acquired a new position in shares of Alignment Healthcare in the first quarter valued at approximately $34,000. First Quadrant LLC CA acquired a new position in shares of Alignment Healthcare in the first quarter valued at approximately $47,000. US Bancorp DE lifted its position in shares of Alignment Healthcare by 15.8% in the second quarter. US Bancorp DE now owns 6,704 shares of the company's stock worth $76,000 after purchasing an additional 914 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Alignment Healthcare by 10.4% in the first quarter. Victory Capital Management Inc. now owns 11,124 shares of the company's stock worth $107,000 after purchasing an additional 1,045 shares in the last quarter. Finally, Ieq Capital LLC bought a new stake in shares of Alignment Healthcare in the first quarter worth $112,000. Institutional investors and hedge funds own 82.68% of the company's stock.

幾家機構投資者和對衝基金最近改變了他們在ALHC的頭寸。NISA Investment Advisors LLC在第一季度收購了Align Healthcare的新頭寸,價值約3.4萬美元。第一跨駿有限責任公司在第一季度收購了Align Healthcare的新股份,價值約為4.7萬美元。US Bancorp DE在第二季度將其在Align Healthcare的股票頭寸提高了15.8%。US Bancorp DE現在擁有該公司6704股股票,價值7.6萬美元,此前在上個季度又購買了914股。第一季度,勝利資本管理公司將其在Align Healthcare的持股比例提高了10.4%。勝利資本管理公司現在持有11,124股該公司股票,價值10.7萬美元,該公司在上個季度又購買了1,045股。最後,IEQ Capital LLC在第一季度購買了Align Healthcare價值11.2萬美元的新股。機構投資者和對衝基金持有該公司82.68%的股票。

About Alignment Healthcare

關於Align Healthcare

(Get Rating)

(獲取評級)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.

Align Healthcare,Inc.是一家技術支持的Medicare Advantage公司,運營着以消費者為中心的醫療保健平臺。它通過其Medicare Advantage計劃在美國為老年人和那些需要它的人提供定製的醫療保健。該公司在加利福尼亞州、北卡羅來納州和內華達州擁有Medicare Advantage計劃。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
  • What Is WallStreetBets and What Stocks Are They Targeting?
  • Institutions And Analysts Propel Jack In The Box Higher
  • Can You Guess Which EV Stock Is Beating Tesla ?
  • Look at Honeywell for a Steady and Diversified Stock
  • Why Invest in High-Yield Dividend Stocks?
  • 免費獲取StockNews.com關於Align Healthcare(ALHC)的研究報告
  • 什麼是WallStreetBets,他們的目標是什麼股票?
  • 機構和分析師推動Jack in the Box走高
  • 你能猜到哪個電動車股票打敗了特斯拉嗎?
  • 霍尼韋爾看好穩定和多元化的股票
  • 為什麼要投資高收益股利股票?

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

接收Align Healthcare Daily的新聞和評級-在下面輸入您的電子郵件地址,以便通過MarketBeat.com的免費每日電子郵件時事通訊接收對Align Healthcare和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論